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Background. We have developed a device for the simplified collection of a prepurified 
sample of saliva in the mouth. 
Method. The device is based on the principle of an osmotic pump and accumulates about 
1.2 ml of an ultrafiltrate of saliva within 8 min. We have investigated the ultratihrate for its 
utility as a biological medium in the evaluation of cigarette smoking status. 
Results. (a) In 58 matched samples from 13 subjects, the correlation coefficient for the 
cotinine concentration in the saliva and the ultrafiltrate was 0.95; (b) in matched plasma and 
ultrafdtrate samples from 27 smokers, the correlation coefficient for the cotinine concen- 
trations was 0.96 with plasma containing 1.2 times the ultrafiltrate mean; (c) in a nonsmoker, 
elevated cotinine levels could be detected in the ultrafiltrate more than 24 hr after smoking 
2 cigarettes, and the pattern of rise and decrease reflected that in whole saliva; and (d) in a 
habitual smoker, the mean cotinine concentration in the ultraflltrate was 157 &ml (SD t 
25.7 @ml) during a period of smoking 15 cigarettes per day and dropped to a mean of 47 
r&ml (SD * 10.5) when smoking was reduced to 5 cigarettes per day; after cessation of 
smoking, detectable concentrations of cotinine persisted for up to 5 days. 
Conclusion. The device facilitated the aesthetic, noninvasive collection of a biological 
sample useful in the validation of smoking status. 0 1992 Academic Press. Inc. 
INTRODUCTION 
Traditionally, determinations of physiologically active substances have been 
made using blood as the biological medium. The collection of body fluids by 
invasive methods has its limitations for obtaining data that require measurements 
from large populations in diverse settings (e.g., in epidemiological studies and in 
longitudinal studies involving infants, children, adolescents, adults, smokers, and 
nonsmokers). Obtaining biological fluids by simple, acceptable, noninvasive 
methods will simplify such investigations. Urine sampling, although noninvasive, 
cannot be considered as an ideal solution for large-scale studies. From this per- 
spective, it is not surprising that until 1987, little information was available on 
smoke intake in adolescents based on biochemical measures (l-3). Many of the 
pioneering studies on passive exposure to tobacco smoke before the mid-1980s 
were carried out in small numbers of subjects and in somewhat atypical samples 
such as hospital outpatients (4) or men attending health screening examinations 
(5). 
Recently, substantial progress has been made in studies using saliva as a me- 
dium from comparatively large numbers of individuals for the investigation of 
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tobacco smoking (6, 7). Quantitative evaluation of passive exposure to tobacco 
smoke has also become more accurate (8); see also (9). Without noninvasive 
sample collection from a comparatively large number of subjects, these studies 
would have been almost impossible. 
The half-lives of cotinine in plasma, urine, and saliva are similar (l&12), so 
that, in principle, any of these liquids can be used for diagnostic determinations. 
Mean concentrations in plasma and saliva are very similar to one another, with 
concentrations in urine being about twice as high (13). Since the excretion rate in 
urine can vary substantially with the volume of liquid uptake, however, values 
obtained from urine are usually much less reliable, unless an additional determi- 
nation of creatinine is made to correct for excretion rates. 
In comparison, salivary flow rate does not affect significantly the concentration 
of cotinine (14, 15). Although a good intercorrelation among cotinine concentra- 
tions in three body fluids-plasma, urine, and saliva-has been reported (4, 16), 
there is still some unexplained variability between plasma and saliva values (17, 
18). The problems include elevated cotinine readings following heavy exposure 
and erratic values for nicotine (17). Possibly some of this unexplained variability 
is related to certain technical limitations in the use of expectorated saliva as a 
medium. Collection and processing present many difficulties. Food intake can 
affect the consistency and appearance of saliva for up to several hours and can 
contribute gross contaminants; saliva also can be contaminated with traces of 
blood. Saliva always contains nonfood particulate matter (oral squames), muco- 
polysaccharides, and mucoproteins that contribute to its highly viscous, 
“stringy, ” “sticky” consistency. Some drugs are known to bind to cellular debris 
and make an accurate estimation in saliva difficult (19). 
The viscosity of saliva makes it extremely difficult to handle in the laboratory. 
The general, albeit time-consuming, method of centrifugation to separate undis- 
solved matter from the solute has met with only limited success. Pipetting and 
aliquoting are laborious as well as extremely inaccurate. Therefore, technicians 
often show an aversion to handling saliva samples. Further, some people resist 
expectorating. The collection procedure is not straightforward and is difficult to 
accomplish in an inconspicuous and aesthetically pleasing way. Consequently, the 
request for samples of saliva sometimes leads to a psychological block that results 
in a “dry mouth.” 
We have developed a saliva collection device that overcomes many of the 
above-mentioned technical and aesthetic problems (20-22). It consists of a semi- 
permeable membrane that encloses an osmotically active substance. When the 
device is kept in the mouth, salivary flow is moderately stimulated. A clear, 
protein-free aqueous ultrafiltrate of saliva is obtained in situ during the process of 
collection. The protein-bound fraction of drugs and other substances from poten- 
tial blood contamination is excluded, and potential degradative processes, such as 
further enzymatic metabolism, are almost totally eliminated. Unlike whole saliva, 
the ultrafiltrate does not require centrifugation, since no precipitate is present. 
The device can be used for the collection of saliva by untrained individuals in 
an aesthetic way for subsequent nicotine/cotinine measurements. It facilitates 
collection in studies involving large numbers of subjects; collection in nonmedical 
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facilities; collection in schools, workplaces, and at home; and collection of saliva 
from clients of insurance companies. In this communication, we report on the 
validation of the ultrafiltrate, collected in the mouth, for the measurement of 
nicotine and cotinine. 
MATERIALS AND METHODS 
Collection Device 
The device consisted of a semipermeable cellulose membrane (20 p,rn thickness; 
molecular cutoff: 12,000 Da; Cuprophan; Enka AG, Germany) composed of two 
discs (35 mm diameter) bonded with polyurethane (Tycel; Lord Corporation, 
Erie, PA) at the periphery, the adhesive forming a ring of 5 mm width. Granular 
sucrose (0.75 g) was deposited inside the membrane. After collection of the ul- 
trafiltrate of saliva, the liquid was extracted prior to assaying by puncturing the 
membrane with a hypodermic needle and transferred with disposable pipettes. 
Sample Collection 
Samples were collected from 13 volunteers (seven males and six females) be- 
tween 20- and 46-years-old who were habitual smokers and reported smoking 
between 5 and 30 cigarettes per day (self-reported; mean: 18.8; SD -+ 7). Unless 
otherwise indicated, at least 60 min was allowed to elapse after smoking of the last 
cigarette before sample collection. Saliva was obtained by spitting into a 12-ml 
polypropylene jar. Subjects were advised to accumulate saliva for about 5 min in 
the mouth before expelling saliva into the container. This reduces frequent ex- 
pelling of froth that contains little liquid. After the collection of whole saliva, the 
subjects collected ultrafiltrate with the device. The device was immersed in tap 
water for a few seconds and then placed into the mouth. Subjects were notified to 
rotate the device frequently in the mouth. The device was expelled by dropping 
into a polycarbonate container (30 ml) after a minimum of 8 min. The collected 
volume of ultrafiltrate was 1.2 +- 0.1 ml (mean ? SD). Subjects were instructed 
not to touch the device or any parts of the inside of the containers to avoid 
contamination with residues of nicotine. 
In a second study, 27 male smokers ranging in age from 23 to 44 (mean + SD 
= 32.9 rt 6.0 years) and smoking 15-30 cigarettes per day (mean + SD = 22.6 & 
4.7) were recruited from the local community to participate in a laboratory study 
of predictors of ability to abstain from smoking. Blood samples were withdrawn 
from subjects 1 week after they were challenged to abstain from smoking, with a 
monetary bonus paid to those who succeeded in reaching cotinine values of 0 
&ml. At that time, a sample of ultrafiltrate of saliva was obtained as well for 
purposes of the present study. This procedure enabled us to obtain data for 
cotinine levels over a wide range of values, since the sample included subjects 
who were entirely successful in abstaining, subjects who were partially success- 
ful, and subjects who did not change their smoking behavior. Nicotine levels were 
also analyzed. 
In a third study, a nonsmoking, 46-year-old, healthy male volunteer was re- 
cruited. The subject smoked two cigarettes (Marlboro Lights; tar: 11 mg; nicotine: 
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0.8 mg; carbon monoxide: 12 mg per cigarette) by inhaling the smoke. Samples 
(saliva and ultrafiltrate) were collected as described above prior to smoking and 
thereafter in different intervals up to 28 hr after smoking. All samples were col- 
lected at home, stored in the home freezer, and brought to the laboratory after the 
collection was completed. 
In a fourth study, a habitually smoking, 21-year-old, healthy female volunteer 
was recruited. After smoking an average of 15 cigarettes per day (13 to 16), the 
subject remained abstinent for 14 days and then resumed smoking (4 to 7 ciga- 
rettes per day). Samples were collected as described above before, during and 
after stopping smoking. Samples were also collected at home, stored in the 
freezer, and brought to the laboratory after the collection was completed. 
Sample Preparation 
All samples were stored at - 20°C prior to analysis. Whole saliva was centri- 
fuged before extraction to remove particulate matter. The semipermeable mem- 
brane of the devices was punctured with a Pasteur glass pipette and the ultrafil- 
trate was measured for density, C,. To this end, 1 ml of liquid was weighed on an 
analytical balance at 22°C. Blood samples were collected in EDTA tubes, the 
precipitate was separated by centrifugation at 4°C and the plasma was stored 
frozen until analyzed. 
Sample Analysis 
Saliva and ultrafiltrate was assayed for nicotine and cotinine by HPLC accord- 
ing to a method described for plasma (23). Briefly, 2-phenylimidazole was added 
as internal standard to the samples prepared as described above, the liquids were 
extracted with methylene chloride after deproteinization with trichloroacetic acid, 
and the organic solvent was evaporated and the residue reconstituted in 30 111 of 
mobile phase for HPLC separation. The limits of detection for nicotine and coti- 
nine are 1 and 3 t&l, respectively. The quantitative analysis was performed in Dr. 
M. Hariharan’ s laboratory. 
The ultrafiltrate contains sucrose that displaces a certain volume of pipetted 
ultrafiltrate. To account for the concentration of analytes in the aqueous compo- 
nent, we calculated a correction factor, f, derived from the density, C,, of the 
solution. The correction factor as a function of the density follows a polynomial 
regression according to the equation (22): 
f = 426.8 - 1495X, + 196X,* - 1146Cw3 -I- 250.8Cw4. 
The concentration for the aqueous medium of the ultrafiltrate is obtained by 
multiplying the concentration determined for the ultrafiltrate by the factor f (i.e., 
actual concentration = f x measured concentration). 
RESULTS 
Collection using the device was considered by 75% of the first users to be more 
convenient and aesthetic than spitting. When subjects used the device more than 
one time, all preferred this method of sample collection. 
COTININE IN SALIVA 
Correlation of Cotinine Concentrations in Saliva vs Ultrafiltrate 
67 
Cotinine concentrations in saliva and ultrafiltrate were highly correlated (r = 
0.95; Fig. 1, left). The liquid in the osmotic device contained about 74% of the 
cotinine in saliva. The concentration of nicotine in saliva and the ultrafiltrate 
correlated moderately (r = 0.76) and the linear regression followed the equation 
y = 8.8 x 0.8~. Between 71 and 80% of the concentration in saliva was found in 
the ultrafiltrate. Nicotine values were out of the expected range (the majority >50 
rig/ml), suggesting that nicotine from contact with cigarette remains sequestered in 
the mouth for more than 1 hr. 
Correlation of Cotinine Concentrations in Plasma vs Saliva VEtraJiltrate 
Mean plasma cotinine +-SD for the 27 subjects in the second study was 162.4 + 
117.3 rig/ml (Fig. 1, right). Using a constant correction factor of 1.25, the corre- 
sponding saliva ultrafiltrate value was 135.4 + 99.1. Thus, plasma mean was 1.2 
times the ultrafiltrate mean. The Pearson correlation coeffkient of plasma with 
ultrafiltrate values for the 27 subjects was 0.96. 
The mean density (+SD) for the 12 subjects for whom density data were avail- 
able was 1.21 2 0.9. The mean plasma level for these 12 subjects was 135.5 k 
128.0 &ml and the corrected mean ultrafiltrate level was 108.1 5 104.5 &ml, 
resulting in a plasma mean that was 1.25 that of the ultrafiltrate mean. Correlation 
of plasma values with corrected ultrafiltrate values yielded a correlation coefft- 
cient of 0.99. 
The study did not produce meaningful nicotine data. For several subjects, nic- 
otine values exceeded 200 &ml, and for two the values exceeded 800 rig/ml; no 
subject, even those with O-nicotine levels using plasma data, achieved ultrafiltrate 
levels of 0 &ml. 
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FIG. 1. (Left) Correlation of cotinine concentrations in saliva and the ultratiltrate of saliva in 58 
matched samples. The equation for linear regression is y = 11.57 + 0.74~; the correlation coefftcient 
is r = 0.95. (Right) Correlation of cotinine concentrations between plasma and the ultrafiltrate of saliva 
in 27 matched samples. The equation for linear regression is y = 5.39 + 0.80x; r = 0.96. 
68 SCHRAMM ET AL. 
Cotinine and Nicotine Levels in Saliva and in the Ultrafiltrate of a Nonsmoker 
After smoking two cigarettes, the nicotine and cotinine concentrations in the 
ultraliltrate of the nonsmoker increased within a few minutes. While the nicotine 
concentration rose abruptly within 15 min to values exceeding 300 rig/ml, cotinine 
increased steadily to reach about 20 r&ml 2 hr after smoking (Fig. 2). Nicotine 
concentrations, artificially elevated until 2 hr fell rapidly to reach baseline levels 
after about 6 hr. Cotinine concentrations, however, were still significantly higher 
after 25 hr than presmoking levels. 
The patterns of nicotine and cotinine concentration were similar in whole saliva 
and in the ultrafiltrate (Fig. 3). It is almost certain that the immediate rise of 
nicotine after smoking to >300 &ml does not reflect concentrations in the blood 
circulation but originates from the sequestered substance in the buccal cavity. 
Cotinine and Nicotine Levels before, during, and after Temporary Abstinence 
in a Regular Smoker 
Cotinine concentrations of a subject smoking an average of 15 cigarettes per day 
were between 120 and 210 &ml in the ultrafiltrate of saliva (Fig. 4). After ces- 
sation of smoking, the concentration was still significantly higher than baseline 
levels at 5 days (3.6 rig/ml). Immediately after resuming smoking, cotinine con- 
centrations rose and remained between 30 and 60 rig/ml. During this period, the 
person smoked only about 5 cigarettes per day. 
At the time of abstinence, elevated nicotine levels were occasionally measured. 
Since failure to detect cotinine tends to confirm the subject’s self-report of absti- 
nence, these small elevations probably resulted from passive smoking. After re- 
suming smoking (average of 5 cigarettes per day), little difference in the concen- 
tration of nicotine to the period of abstinence can be observed. 
DISCUSSION 
Saliva can be obtained noninvasively and is therefore superior to blood as a 
biological medium for many applications. Whether saliva is preferable to urine 
may depend on the circumstances: the controversies over invasion of privacy 
t 
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FIG. 2. Concentration of nicotine (nit) and cotinine (cot) over time in the ultrafiltrate of saliva of a 
nonsmoker after smoking two cigarettes (at 170 min). After more than 1 day (1,700 min), the elevation 
of cotinine was still significant. 
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FIG. 3. Concentration of nicotine (nit) and cotinine (cot) over time in the whole saliva of a non- 
smoker. The samples were simultaneously collected with those as shown in Fig. 2. 
regarding the collection of urine samples for the assessment of drug abuse are well 
known; on the other hand, a patient visiting the physician might prefer to provide 
a urine sample than to expectorate. In appreciation of these limitations, methods 
have been developed to collect saliva by means of cotton plugs (dental roll) that 
are subsequently centrifuged to extract liquid. High nonspecific binding of ana- 
lytes can be expected on the large surface area, however, and caution has been 
recommended in using such methods (24, 25). The device used in this study has a 
much smaller surface area. It also prepurifies saliva in situ by excluding particu- 
late matter and molecules >12,000 Da, thus yielding a clear liquid within a few 
minutes that does not need to be centrifuged. 
The volume of ultrafiltrate that was collected in 8 min was sufftcient for the 
quantitative analysis by HPLC. The determination of cotinine by immunoassay 
requires even less volume, i.e., about 25 ul. If, for other applications, more 
sample volume should be required, two of the devices can be used either simul- 
taneously or consecutively. 
A disadvantage of using the ultratiltrate seems to be the monitoring of the 
density for calculating the concentration of analytes. Variability of density is quite 
small, however, so that in instances in which determining the density poses dif- 
0 5 10 15 20 25 
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FIG. 4. Concentration of cotinine over time in the ultratiltrate of saliva of an individual who smoked 
an average of 15 cigarettes per day (15/d), stopped smoking (O/d), and resumed smoking (average of 5 
cigarettes per day, 5/d). 
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FIG. 5. Concentration of nicotine over time in the ultrafiltrate of saliva in the same samples as 
shown in Fig. 4. Nicotine is a less reliable indicator of smoking than the metabolite cotinine. 
ficulties, the use of a constant produces satisfactory results (e.g., an average 
density of 1.12 g/ml in this study). 
In these and similar experiments (20-22), we have not experienced breakage of 
the semipermeable membrane, although subjects were instructed not to chew on 
the device. If more protection should be required for other applications (e.g., for 
the involuntary collection of ultrafiltrate) the osmotic device can be enclosed in a 
perforated silicon sleeve. 
We have demonstrated that the device can be used for the quantitative deter- 
mination of cotinine in saliva. The validity of saliva as a medium for the measure- 
ment of cotinine has been previously established in studies comparing concentra- 
tions and correlations among saliva, plasma, and urine (10-13). Our investigations 
have shown an excellent correlation between cotinine concentrations in whole 
saliva and the ultraliltrate, and between plasma and the ultrafiltrate (Fig. 1). The 
concentrations of nicotine correlate less in the three media. 
Nicotine is metabolized to more than 20 different derivatives (26). The major 
metabolite is cotinine, which is specific to tobacco smoking, tobacco chewing, 
and the use of nicotine gum. With an average half-life of about 19 hr in smokers 
(27), this derivative is an excellent marker for nicotine exposure. It has been 
widely used as a biological marker of smoking in epidemiological studies (4, 6-8, 
10, 28, 29). The concentration of cotinine in body fluids can give an estimate of 
nicotine exposure for up to 2 or 3 days after cigarette smoking. In fact, we 
demonstrated elevated cotinine levels in the ultrafiltrate and in whole saliva for 
more than 24 hr after smoking of two cigarettes by a nonsmoker (Figs. 2 and 3). 
The patterns for concentration over time were similar in the two fluids. 
Cotinine concentrations in the ultrafiltrate are clearly related to the number of 
cigarettes smoked per day. While the mean concentration of cotinine was 157 
rig/ml (SD k25.7 rig/ml) when the subject reported smoking a mean of 15 cigarettes 
per day, the concentration was 47 rig/ml (SD k10.5) during the 10 days that the 
subject reported smoking a mean of 5 cigarettes per day (Fig. 4). Such a dose- 
response relationship, however, may extend only to samples from the same indi- 
vidual, because metabolism of nicotine to cotinine can vary substantially between 
individuals, depending on age, sex, and smoker vs. non-smoker (11, 30). 
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After cessation of smoking by a habitual smoker, elevated cotinine levels could 
be detected for up to 5 days (3 &ml; Fig. 4). It is very difficult to compare these 
results with similar studies, since large variations in cotinine levels (31) and in 
rates of metabolizing nicotine (32) are possible. Moreover, unless subjects are 
closely supervised in cessation studies, it is not possible to confirm abstinence. 
Elevated cotinine concentrations in saliva (> 10 r&ml) between 3 and 7 days after 
subjects stopped smoking (31), concentrations between 1.6 and 52 rig/ml after 2 
days (32), and a fall of cotinine in “moderate smokers” (not specified) from 615 
to 314 rig/ml 7 days after cessation of smoking (16) have been reported. These 
concentrations can be compared to levels of less than 5 rig/ml in passive smokers, 
although in heavy passive smokers levels >lO rig/ml have been reported (33). 
These experiments presented here were designed to investigate the utility of an 
ultratiltrate of saliva for the measurement of cotinine in a limited number of 
human subjects. It is reasonable to expect that the cost of the device for the 
collection of ultratiltrate, if manufactured on a large scale, should justify its ap- 
plicability in public health studies. To extend the results, future independent 
investigations should address the issues of generalizability and cost-effectiveness 
in field trials, epidemiological studies, and passive exposure to smoke. 
CONCLUSIONS 
The use of the osmotic device facilitated sample collection and processing 
substantially. When the resulting ultratiltrate was assayed for cotinine, concen- 
trations comparable to those in whole saliva and plasma were observed. The 
device thus appears to have many advantages to other available methodologies for 
the determination of smoking status in settings where the noninvasive collection 
of a sample is desired. We are now testing modifications of the device where the 
collector is placed inside a perforated pacifier for studies with children. Another 
version with the collector enveloped by a perforated silicon rubber sleeve for 
protection and with a tether attached that hangs out of the mouth during use (e.g., 
for use by law enforcement agencies) is being developed. 
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